Further, the utility of AFP in HCC screening is limited, since it does not allow distinguishing between cancerous lesions, and other benign liver pathologies, especially in early stages, hence resulting in a high proportion of false positives and false negatives. Here, AFP is linked to hepatocellular carcinoma.